A. Plech et al., ENHANCED ORAL ACTIVITY RESPONSES TO INTRASTRIATAL SKF-38393 AND M-CPPARE ATTENUATED BY INTRASTRIATAL MIANSERIN IN NEONATAL 6-OHDA-LESIONEDRATS, Psychopharmacology, 119(4), 1995, pp. 466-473
Enhanced oral activity is induced in neonatal 6-hydroxydopamine- (6-OH
DA-) lesioned rats by systemic administration of the dopamine (DA) D-1
receptor agonist SKF 38393 and serotonin (5-HT) 5HT(2A,2C) agonist m-
chlorophenylpiperazine (rn-CPP). The DA D-1 receptor antagonist SCH 23
390 effectively attenuates the effect of SKF 38393 but not m-CPP. The
5-HT(2)antagonist mianserin attenuates the effects of both m-CPP and S
KF 38393, suggesting that DA agonist effects are mediated by 5-HT neur
ochemical systems. To test whether DA and 5-HT agonist effects and int
eractions might occur within the neostriatum, rats were implanted with
permanent injection cannulae, with tips in the ventral striatum. One
group of rats was lesioned at 3 days after birth with 6-OHDA HBr (100
mu g salt form, in each lateral ventricle; desipramine HCl pretreatmen
t, 20 mg/kg IF, base form, 1 h), while controls received the vehicle i
n place of 6-OHDA. Cannulae were implanted when rats weighed 200-250 g
. During a l-h observation session SKF 38393 (5 nmol per side) produce
d 74.3 +/- 19.2 oral movements in intact rats and 310.7 +/- 97.0 oral
movements in 6-OHDA-lesioned rats. m-CPP (10 nmol per side) produced 7
2.6 +/- 15.1 and 274.5 +/- 65.0 oral movements in these respective gro
ups. These responses were several-fold greater than the 25.3 +/- 7.3 a
nd 41.8 +/- 9.5 oral movements in the same groups after saline (0.5 mu
l per side) (P < 0.05). Mianserin (6 nmol per side) alone had no effe
ct on oral activity but attenuated responses to both SKF 38393 and m-C
PP in intact and 6-OHDA-lesioned rats. These findings demonstrate that
enhanced oral activity responses are produced by intrastriatal SKF 38
393 and m-CPP in neonatal 6-OHDA-lesioned rats. Also, when the 5-HT2 r
eceptor antagonist mianserin was administered intrastriatally, inducti
on of oral activity by the DB D-1 agonist SKF 38393 was attenuated. Th
ese findings indicate that ventral striatum represents at least one br
ain focus at which DA and 5-HT systems interact to modulate oral activ
ity in rats.